These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 3128548

  • 1. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
    Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA, Loskutoff DJ.
    J Biol Chem; 1988 Apr 25; 263(12):5797-803. PubMed ID: 3128548
    [Abstract] [Full Text] [Related]

  • 2. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
    Sawdey M, Podor TJ, Loskutoff DJ.
    J Biol Chem; 1989 Jun 25; 264(18):10396-401. PubMed ID: 2499579
    [Abstract] [Full Text] [Related]

  • 3. Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Comparison with plasminogen activator inhibitor-1 synthesis.
    Zoellner H, Wojta J, Gallicchio M, McGrath K, Hamilton JA.
    Thromb Haemost; 1993 Feb 01; 69(2):135-40. PubMed ID: 8456426
    [Abstract] [Full Text] [Related]

  • 4. Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells.
    Santell L, Levin EG.
    J Biol Chem; 1988 Nov 15; 263(32):16802-8. PubMed ID: 2460455
    [Abstract] [Full Text] [Related]

  • 5. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
    Michel JB, Quertermous T.
    J Immunol; 1989 Aug 01; 143(3):890-5. PubMed ID: 2501387
    [Abstract] [Full Text] [Related]

  • 6. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
    Kooistra T, Bosma PJ, Toet K, Cohen LH, Griffioen M, van den Berg E, le Clercq L, van Hinsbergh VW.
    Arterioscler Thromb; 1991 Aug 01; 11(4):1042-52. PubMed ID: 1648385
    [Abstract] [Full Text] [Related]

  • 7. Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells.
    Zhang W, Wojta J, Binder BR.
    Arterioscler Thromb; 1994 Jul 01; 14(7):1040-6. PubMed ID: 8018658
    [Abstract] [Full Text] [Related]

  • 8. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
    Mussoni L, Banfi C, Sironi L, Arpaia M, Tremoli E.
    Thromb Haemost; 2000 Jul 01; 84(1):59-64. PubMed ID: 10928471
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo.
    van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ.
    Blood; 1988 Nov 01; 72(5):1467-73. PubMed ID: 3140909
    [Abstract] [Full Text] [Related]

  • 13. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y, Okada M, Noro A, Matsuda M.
    J Biol Chem; 1988 Feb 05; 263(4):1960-9. PubMed ID: 3123483
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modulation by endothelin-1 of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells: interaction of endothelin-1 with cytokines.
    Yamamoto C, Kaji T, Sakamoto M, Kozuka H.
    Biol Pharm Bull; 1993 Jul 05; 16(7):714-5. PubMed ID: 8401409
    [Abstract] [Full Text] [Related]

  • 16. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
    Schleef RR, Podor TJ, Dunne E, Mimuro J, Loskutoff DJ.
    J Cell Biol; 1990 Jan 05; 110(1):155-63. PubMed ID: 2104856
    [Abstract] [Full Text] [Related]

  • 17. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
    Peraldi MN, Rondeau E, Medcalf RL, Hagège J, Lacave R, Delarue F, Schleuning WD, Sraer JD.
    Biochim Biophys Acta; 1992 Apr 07; 1134(3):189-96. PubMed ID: 1558843
    [Abstract] [Full Text] [Related]

  • 18. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
    Hekman CM, Loskutoff DJ.
    Arch Biochem Biophys; 1988 Apr 07; 262(1):199-210. PubMed ID: 3128176
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin-1, endotoxin or tumor necrosis factor/cachectin enhance the level of plasminogen activator inhibitor messenger RNA in bovine aortic endothelial cells.
    Medina R, Socher SH, Han JH, Friedman PA.
    Thromb Res; 1989 Apr 01; 54(1):41-52. PubMed ID: 2499077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.